Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells

International Journal of Oncology

Volumn 13, Issue 5, 1998, Pages 1043-1048

  Burger, Angelika M ^a   Fiebig, Heinz H ^a   Kuettel, Michael R ^b   Lautenberger, James A ^c   Kung, Hsiang Fu ^c   Rhim, Johng S ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GEORGETOWN UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Benign prostate hyperplasia prostate epithelial cells; E6; E7; Fibroblasts; HUVEC; Telomerase activity; Telomeres; Tumorigenicity; V Ki ras

Indexed keywords

ONCOPROTEIN; TELOMERASE;

ARTICLE; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL AGING; CELL IMMORTALIZATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME REACTIVATION; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFECTION; HERPES VIRUS; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; ONCOGENE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; SIMIAN VIRUS 40; TELOMERE; VASCULAR ENDOTHELIUM;

EID: 0031763632     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.5.1043     Document Type: Article

References (25)

1. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
2. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin G, Harley C, Shay JW, Lichtsteiner S and Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 279: 335-349, 1998.
3. Bacchetti S and Wynford-Thomas D: Telomeres and telomerase in cancer. Eur J Cancer 33: 703-800, 1997.
4. Rhyu MS: Telomeres, telomerase, and immortality. J Natl Cancer Inst 87: 884-894, 1995.
5. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274, 1997.
6. Rhim JS, Tsai WP, Chen ZQ, Chen Z, van Waes C, Burger AM and Lautenberger JA: A human vascular endothelial cell model to study angiogenesis and tumorigenesis. Carcinogenesis 19: 673-681, 1998.
7. Kaighn ME, Reddel RR, Lechner JF, Peehl DM, Camalier RF, Brash DE, Saffiotti U and Harris CC: Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res 49: 3050-3056, 1989.
8. Rhim JS, Webber MM, Bello D, Lee MS, Arnstein P, Chen LS and Jay G: Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc Natl Acad Sci USA 91: 11874-11878, 1994.
9. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
10. Burger AM, Bibby MC and Double JA: Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. Br J Cancer 75: 516-522, 1997.
11. Klingelhutz AJ, Barber SA, Smith PP, Dyer D and McDougall JK: Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol 14: 961-969, 1994.
12. Silhavy TJ, Berman ML and Enquist LW: Experiments with gene fusions. Cold Spring Harbor Laboratory Press, 1984.
13. Sambrook J, Fritsch EF and Maniatis T: Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, 1989.
14. Parda DS, Thravcs PJ, Kuettel MR, Lee MS, Arnstein P, Kaighn ME, Rhim JS and Dritschilo A: Neoplastic transformation of a human prostate epithelial cell line by v-Ki-ras oncogene. Prostate 23: 91-98, 1993.
15. Kuettel MR, Thraves P, Jung M, Varghese SP, Prasad SC, Rhim JS and Dritschilo A: Radiation-induced neoplastic transformation of human prostate epithelial cells. Cancer Res 56: 5-10, 1996.
16. Hablert CL, Demers GW and Galloway DA: The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol 66: 2125-2134, 1992.
17. Bryan TM and Reddel RR: SV40-induced immortalization of human cells. Crit Rev Oncol 5: 331-357, 1994.
18. Lee MS, Garkovenko E, Yun JS, Weijerman PC, Pechl DM, Chen LS and Rhim JS: Characterization of adult human prostatic epithelial cells immortalized by polybrene induced DNA transfection with a plasmid containing an origin defective SV40 genome. Int J Oncol 4: 821-830, 1994.
19. Klingelhutz AJ, Foster SA and McDougall JK: Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79-82, 1996.
20. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW and Coffey DS: Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56: 218-222, 1996.
21. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M and Kubota Y: Telomerase activity in primary prostate cancer. J Urol 157: 1161-1165, 1997.
22. Zhang W, Kapusta LR, Shingerland JM and Klotz LH: Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res 58: 619-621, 1998.
23. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics. CA Cancer J Clin 47: 5-27, 1997.
24. Smith JR and Pereira-Smith OM: Replicative senescence: implications for in vivo aging and tumor suppression. Science 273: 63-67, 1996.
25. Blasco MA, Lee HW, Hande MP, Samper E, Landsdorp PM, De Pinho RA and Greider CW: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34, 1997.